Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Bundred

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|July 12, 2011
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?Nigel J Bundred, Ramachandran Prasad, Julie Morris, et al.
The British Journal of Radiology|December 15, 2015
Randomized controlled trial of stereotactic 11-G vacuum-assisted core biopsy for the diagnosis and management of mammographic microcalcificationSara M Bundred, Anthony J Maxwell, Julie Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized TrialMangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Breast Cancer Research : BCR|July 1, 2009
Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancerFiona M Foster, Thomas W Owens, Jolanta Tanianis-Hughes, et al.
Cancer Research|January 10, 2002
Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breastKai C Chan, W Fiona Knox, Julia M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma <i>in situ</i>: Results from the UK/ANZ DCIS TrialMangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Breast Cancer Research and Treatment|April 9, 2015
Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancerNigel J Bundred, Charlotte Stockton, Vaughan Keeley, et al.
Cancer Research|January 14, 2010
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptorHannah Harrison, Gillian Farnie, Sacha J Howell, et al.
Cancer Medicine|December 12, 2022
Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMINigel J Bundred, Emma Barrett, Chriss Todd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanismsJagdeep K Singh, Gillian Farnie, Nigel J Bundred, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|July 12, 2011
Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?Nigel J Bundred, Ramachandran Prasad, Julie Morris, et al.
The British Journal of Radiology|December 15, 2015
Randomized controlled trial of stereotactic 11-G vacuum-assisted core biopsy for the diagnosis and management of mammographic microcalcificationSara M Bundred, Anthony J Maxwell, Julie Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized TrialMangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Breast Cancer Research : BCR|July 1, 2009
Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancerFiona M Foster, Thomas W Owens, Jolanta Tanianis-Hughes, et al.
Cancer Research|January 10, 2002
Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breastKai C Chan, W Fiona Knox, Julia M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma <i>in situ</i>: Results from the UK/ANZ DCIS TrialMangesh A Thorat, Pauline M Levey, J Louise Jones, et al.
Breast Cancer Research and Treatment|April 9, 2015
Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancerNigel J Bundred, Charlotte Stockton, Vaughan Keeley, et al.
Cancer Research|January 14, 2010
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptorHannah Harrison, Gillian Farnie, Sacha J Howell, et al.
Cancer Medicine|December 12, 2022
Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMINigel J Bundred, Emma Barrett, Chriss Todd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanismsJagdeep K Singh, Gillian Farnie, Nigel J Bundred, et al.
Pageof 5